Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus
Utako Yokoyama, … , Yukihiko Sugimoto, Yoshihiro Ishikawa
Utako Yokoyama, … , Yukihiko Sugimoto, Yoshihiro Ishikawa
Published November 1, 2006
Citation Information: J Clin Invest. 2006;116(11):3026-3034. https://doi.org/10.1172/JCI28639.
View: Text | PDF
Research Article Cardiology

Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus

Abstract

PGE, a potent vasodilator, plays a primary role in maintaining the patency of the ductus arteriosus (DA). Genetic disruption of the PGE-specific receptor EP4, however, paradoxically results in fatal patent DA (PDA) in mice. Here we demonstrate that EP4-mediated signals promote DA closure by hyaluronic acid–mediated (HA-mediated) intimal cushion formation (ICF). Chronic EP4 stimulation by ONO-AE1-329, a selective EP4 agonist, significantly enhanced migration and HA production in rat DA smooth muscle cells. When HA production was inhibited, EP4-mediated migration was negated. Activation of EP4, adenylyl cyclase, and PKA all increased HA production and the level of HA synthase 2 (HAS2) transcripts. In immature rat DA explants, ICF was promoted by EP4/PKA stimuli. Furthermore, adenovirus-mediated Has2 gene transfer was sufficient to induce ICF in EP4-disrupted DA explants in which the intimal cushion had not formed. Accordingly, signals through EP4 have 2 essential roles in DA development, namely, vascular dilation and ICF. The latter would lead to luminal narrowing, helping adhesive occlusion and permanent closure of the vascular lumen. Our results imply that HA induction serves as an alternative therapeutic strategy for the treatment of PDA to the current one, i.e., inhibition of PGE signaling by cyclooxygenase inhibitors, which might delay PGE-mediated ICF in immature infants.

Authors

Utako Yokoyama, Susumu Minamisawa, Hong Quan, Shibnath Ghatak, Toru Akaike, Eri Segi-Nishida, Shiho Iwasaki, Mari Iwamoto, Suniti Misra, Kouichi Tamura, Hideaki Hori, Shumpei Yokota, Bryan P. Toole, Yukihiko Sugimoto, Yoshihiro Ishikawa

×

Figure 3

HA production is mediated by PGE/EP4/PKA signal in DA SMCs.

Options: View larger image (or click on image) Download as PowerPoint
HA production is mediated by PGE/EP4/PKA signal in DA SMCs. (A) HA produ...
(A) HA production after 48-hour stimulation with agents. PGE1, PGE2, and ONO-AE1-329 at 10–6 M dramatically increased HA production in the DA but not in the aorta. ONO-AE3-208 (10–6 M), an EP4 antagonist, almost abolished the effect of PGE1 (10–6 M). The ONO-AE1-329–induced HA production was significantly attenuated by transfection with rat HAS2 siRNA (100 pmol) or H89. Forskolin (10–5 M) and pCPT-cAMP (10–4 M) significantly increased HA production in both the DA and aortic SMCs. Sulprostone (10–6 M), an EP1/3-selective agonist, and butaprost (10–6 M), an EP2-selective agonist, had little effect on HA secretion in DA SMCs. TGF-β (10 ng/ml) and PDGF-BB (10 ng/ml) significantly increased HA production in the aorta but not in the DA. n = 4–8; **P < 0.01, #P < 0.001 compared with control. †P < 0.05, ††P < 0.01, ΧP < 0.001 compared with aorta. (B) Dose-dependent HA production after 48-hour stimulation with ONO-AE1-329. (C) Time-dependent HA production stimulated by 10–6 M ONO-AE1-329. n = 4; **P < 0.01, #P < 0.001 compared with control. ND, not done.